AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20179751 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard 6 month anti-tuberculosis (TB) therapy
Number of subjects: 38
Study 18625184 — intervention group
Group type: EXPERIMENTAL
Intervention: Propensity score methodology
Number of subjects: 0
Study 18625184 — intervention group
Group type: COMPARATOR
Intervention: Randomized control trials
Number of subjects: 0
Study 16052109 — intervention group
Group type: EXPERIMENTAL
Intervention: Entropy group (anesthesia with entropy values shown)
Number of subjects: 368
Study 16052109 — intervention group
Group type: COMPARATOR
Intervention: Control group (anesthesia with entropy values not shown)
Number of subjects: 368
Study 11790638 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal xanomeline, an M1‐selective cholinergic agonist, administered for 4 months.
Number of subjects: 0
Study 11790638 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered for 4 months.
Number of subjects: 0
Study 10618939 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal paracetamol 1.3 g
Number of subjects: 72
Study 10618939 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 50 mg
Number of subjects: 72
Study 10618939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 10618939 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal paracetamol and diclofenac
Number of subjects: 72
Study 10618939 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 72
Study 8543846 — intervention group
Group type: EXPERIMENTAL
Intervention: hMG preparation containing a 3:1 ratio of FSH/LH (Group A)
Number of subjects: 84
Study 8543846 — intervention group
Group type: COMPARATOR
Intervention: hMG at an FSH/LH 1:1 ratio (Group B)
Number of subjects: 84
Study 8543846 — intervention group
Group type: COMPARATOR
Intervention: Pure FSH (Group C)
Number of subjects: 84
Study 1935730 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxamniquine 750 mg
Number of subjects: 5
Study 1935730 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxamniquine 1000 mg
Number of subjects: 5
Study 1935730 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxamniquine 1250 mg
Number of subjects: 5
Study 1935730 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxamniquine (all doses)
Number of subjects: 5
Study 6775094 — intervention group
Group type: EXPERIMENTAL
Intervention: medroxyprogesterone acetate, 20 mg
Number of subjects: 27
Study 6775094 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study 30422368 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 10 mg once daily
Number of subjects: 50
Study 30422368 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg once daily
Number of subjects: 50
Study 30422368 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole (10 mg or 20 mg)
Number of subjects: 50
Study 28475373 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 40 mg/day
Number of subjects: 326
Study 28475373 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 80 mg/day
Number of subjects: 326
Study 28475373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study 26399101 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (15-20 mm tibial stump)
Number of subjects: 42
Study 26399101 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (5-10 mm tibial stump)
Number of subjects: 42
Study 26399101 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 42
Study 24502859 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (2-15 mg/d)
Number of subjects: 85
Study 24502859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 24502859 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 85
Study 22148961 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein Ingestion (WPI)
Number of subjects: 31
Study 22148961 — intervention group
Group type: COMPARATOR
Intervention: Resistance Exercise
Number of subjects: 31
Study 22148961 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise and WPI
Number of subjects: 31
Study 20829497 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg)
Number of subjects: 12
Study 20829497 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sucrose)
Number of subjects: 12
Study 17507833 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogens (CEE) 0.625 mg/d
Number of subjects: 27
Study 17507833 — intervention group
Group type: COMPARATOR
Intervention: Transdermal estradiol (TD E2) 0.05 mg/d
Number of subjects: 27
Study 15843081 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG
Number of subjects: 6
Study 15843081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 12197589 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based intervention (tailoring two family members, one adult and one child)
Number of subjects: 180
Study 12197589 — intervention group
Group type: COMPARATOR
Intervention: Individual-based intervention (tailoring one family member, one adult or one child)
Number of subjects: 180
Study 12197589 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored fat feedback letters (both conditions)
Number of subjects: 180
Study 9654760 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysphoric targets expected to be nondysphoric
Number of subjects: 240
Study 9654760 — intervention group
Group type: COMPARATOR
Intervention: Nondysphoric targets
Number of subjects: 240
Study 8270459 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast neutron irradiation (2040 ncGy)
Number of subjects: 172
Study 8270459 — intervention group
Group type: COMPARATOR
Intervention: Photon irradiation (7000-7020 cGy)
Number of subjects: 172
Study 2564725 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 45
Study 2564725 — intervention group
Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 45
Study 29894865 — intervention group
Group type: EXPERIMENTAL
Intervention: m-health self-management intervention delivered via smartphone apps
Number of subjects: 290
Study 29894865 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 290
Study 27421281 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Back Pain Rating Scale assessment at 1.5 years follow-up
Number of subjects: 120
Study 27421281 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Back Pain Rating Scale assessment at 12 years follow-up
Number of subjects: 120
Study 25659979 — intervention group
Group type: COMPARATOR
Intervention: One meal served on a non-HD day
Number of subjects: 12
Study 25659979 — intervention group
Group type: EXPERIMENTAL
Intervention: One meal served during HD
Number of subjects: 12
Study 25659979 — intervention group
Group type: EXPERIMENTAL
Intervention: Two meals served during and after HD
Number of subjects: 12
Study 25659979 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose infusion
Number of subjects: 12
Study 25659979 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-insulin infusion
Number of subjects: 12
Study 25659979 — intervention group
Group type: COMPARATOR
Intervention: No infusion
Number of subjects: 12
Study 24120179 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic cheese (Lactobacillus plantarum TENSIA), 1500 kcal/d diet for 3 weeks
Number of subjects: 40
Study 24120179 — intervention group
Group type: COMPARATOR
Intervention: Control cheese, 1500 kcal/d diet for 3 weeks
Number of subjects: 40
Study 24120179 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic cheese (Lactobacillus plantarum TENSIA)
Number of subjects: 40
Study 24120179 — intervention group
Group type: COMPARATOR
Intervention: Control cheese
Number of subjects: 40
Study 20419730 — intervention group
Group type: EXPERIMENTAL
Intervention: Group intervention at school
Number of subjects: 195
Study 20419730 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual treatment at a mental health clinic
Number of subjects: 195
Study 20419730 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 195
Study 18701831 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychodynamic psychotherapy (STPP) (1 session/week)
Number of subjects: 51
Study 18701831 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine treatment (20‐40 mg/day)
Number of subjects: 51
Study 18701831 — intervention group
Group type: COMPARATOR
Intervention: Both treatments (STPP and fluoxetine)
Number of subjects: 51
Study 17085376 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT with 1 mg/day micronized 17beta-estradiol and 10 mg/day dydrogesterone for 14 days of each 28-day cycle
Number of subjects: 66
Study 17085376 — intervention group
Group type: COMPARATOR
Intervention: No therapy (Control)
Number of subjects: 66
Study 12653410 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher withdrawal intercepts, positive linear slopes, and greater volatility during abstinence.
Number of subjects: 893
Study 12653410 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette coefficients indicating smoking-induced withdrawal reduction.
Number of subjects: 893
Study 12653410 — intervention group
Group type: EXPERIMENTAL
Intervention: Withdrawal patterns during abstinence.
Number of subjects: 893
Study 12653410 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of withdrawal during abstinence.
Number of subjects: 893
Study 10916100 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 92
Study 10916100 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 92
Study 10916100 — intervention group
Group type: COMPARATOR
Intervention: Losartan and Enalapril (both groups)
Number of subjects: 92
Study 8961578 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital planimetry
Number of subjects: 82
Study 8961578 — intervention group
Group type: EXPERIMENTAL
Intervention: Kundin Wound Gauge
Number of subjects: 82
Study 8961578 — intervention group
Group type: COMPARATOR
Intervention: Healing Scale
Number of subjects: 82
Study 8961578 — intervention group
Group type: COMPARATOR
Intervention: Johnson Scale
Number of subjects: 82
Study 8961578 — intervention group
Group type: COMPARATOR
Intervention: Stereophotogrammetry
Number of subjects: 82
Study 1325762 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg of conjugated estrogen with 2.5 mg of micronized medroxyprogesterone acetate daily continuously (group C-2.5)
Number of subjects: 0
Study 1325762 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg of conjugated estrogen and 5.0 mg of micronized medroxyprogesterone acetate daily continuously (group C-5)
Number of subjects: 0
Study 1325762 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg of conjugated estrogen on days 1 through 25 and 5 mg of micronized medroxyprogesterone acetate on days 14 through 25 (group S-5)
Number of subjects: 0
Study 1325762 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (C-2.5, C-5, S-5)
Number of subjects: 0
Study 6363096 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg once daily metoprolol Durules
Number of subjects: 27
Study 6363096 — intervention group
Group type: COMPARATOR
Intervention: 200 mg metoprolol and 25 mg hydrochlorothiazide (Selokomb)
Number of subjects: 27
Study 6363096 — intervention group
Group type: EXPERIMENTAL
Intervention: Change from double dose of metoprolol Durules to combination therapy
Number of subjects: 27
Study 30885955 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily for 8 weeks
Number of subjects: 32
Study 30025009 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcrestal implants (1 mm subcrestally placed)
Number of subjects: 54
Study 30025009 — intervention group
Group type: COMPARATOR
Intervention: Crestal implants (placed at the bone crest level)
Number of subjects: 54
Study 26655606 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant 0.7 mg
Number of subjects: 0
Study 26655606 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 0
Study 25281042 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 200
Study 25281042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 21519291 — intervention group
Group type: EXPERIMENTAL
Intervention: ACU-4429 (2 mg to 75 mg)
Number of subjects: 0
Study 21253373 — intervention group
Group type: EXPERIMENTAL
Intervention: propofol/remifentanil (PRO/REM)
Number of subjects: 60
Study 21253373 — intervention group
Group type: EXPERIMENTAL
Intervention: sevoflurane/remifentanil (SEV/REM)
Number of subjects: 60
Study 21253373 — intervention group
Group type: EXPERIMENTAL
Intervention: desflurane/remifentanil (DES/REM)
Number of subjects: 60
Study 17439908 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon‐beta1a (IFN‐beta1a), 22 mug subcutaneously weekly
Number of subjects: 345
Study 17439908 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 345
Study 17439908 — intervention group
Group type: EXPERIMENTAL
Intervention: SPMS patients
Number of subjects: 345
Study 17439908 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased fatigue, EDSS and Arm Index scores
Number of subjects: 345
Study 15729227 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive training with compactEASIE simulator (3 sessions over 7 months)
Number of subjects: 37
Study 15729227 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical training
Number of subjects: 37
Study 15729227 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive simulator/clinical training
Number of subjects: 37
Study 11904789 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation Training (PMRT)
Number of subjects: 71
Study 11904789 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard pharmacological antiemetic treatment: metoclopramide and dexamethasone i.v.)
Number of subjects: 71
Study 9651908 — intervention group
Group type: EXPERIMENTAL
Intervention: Menopausal symptoms (presence of hot flashes, irregular menstrual cycles)
Number of subjects: 290
Study 9651908 — intervention group
Group type: EXPERIMENTAL
Intervention: Irregular menstrual cycles
Number of subjects: 290
Study 9651908 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic women
Number of subjects: 290
Study 8919261 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg
Number of subjects: 0
Study 8919261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2774036 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen sodium 0.03%
Number of subjects: 139
Study 2774036 — intervention group
Group type: COMPARATOR
Intervention: No flurbiprofen (Control)
Number of subjects: 139
Study 889379 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacteria Controlled Nursing Unit (BCNU)
Number of subjects: 0
Study 29524454 — intervention group
Group type: EXPERIMENTAL
Intervention: Vamorolone (0.1-20.0 mg/kg single doses; 1.0-20 mg/kg/day for 14 days)
Number of subjects: 86
Study 28279757 — intervention group
Group type: EXPERIMENTAL
Intervention: Hohl manipulator
Number of subjects: 91
Study 28279757 — intervention group
Group type: COMPARATOR
Intervention: Colpo-Probe manipulator
Number of subjects: 91
Study 25786050 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise programme (24 twice-weekly sessions of combined aerobic, muscle strength training exercises and education)
Number of subjects: 76
Study 25786050 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise programme
Number of subjects: 76
Study 25786050 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 76
Study 23924790 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg
Number of subjects: 30
Study 23924790 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab 10 mg/kg + GVAX
Number of subjects: 30
Study 21133742 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 28
Study 21133742 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol/Ketamine (P/K)
Number of subjects: 28
Study 19149323 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-rehabilitation and problem-solving therapy intervention
Number of subjects: 19
Study 19149323 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 19
Study 15673100 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% carbohydrate-electrolyte (CHO-E) solution
Number of subjects: 9
Study 15673100 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate-free placebo (P)
Number of subjects: 9
Study 11895067 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte macrophage-colony stimulating factor (GM-CSF)
Number of subjects: 0
Study 11895067 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 9620134 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler waveform analysis alone
Number of subjects: 81
Study 9620134 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler waveform analysis plus ABI
Number of subjects: 81
Study 9620134 — intervention group
Group type: EXPERIMENTAL
Intervention: Doppler waveform analysis plus SEGP data
Number of subjects: 81
Study 8560525 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (10 mg/kg)
Number of subjects: 16
Study 8560525 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (15 mg/kg)
Number of subjects: 16
Study 2462069 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium etidronate
Number of subjects: 57
Study 2462069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 1245792 — intervention group
Group type: EXPERIMENTAL
Intervention: Chenodeoxycholic acid (CDC), 750 mg per day
Number of subjects: 4
Study 1245792 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital (PB), 90 or 180 mg
Number of subjects: 4
Study 1245792 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CDC and PB
Number of subjects: 4
Study 1245792 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 31787150 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-month individualized, progressive, multicomponent physical exercise program
Number of subjects: 112
Study 31787150 — intervention group
Group type: COMPARATOR
Intervention: Routine activities (Control)
Number of subjects: 112
Study 30796143 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week regimen of doxycycline or clarithromycin/hydroxychloroquine after a 2-week open-label regimen of intravenous ceftriaxone
Number of subjects: 239
Study 30796143 — intervention group
Group type: COMPARATOR
Intervention: 2-week regimen of intravenous ceftriaxone
Number of subjects: 239
Study 28698186 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting serum insulin levels
Number of subjects: 591
Study 28698186 — intervention group
Group type: EXPERIMENTAL
Intervention: Fourth quartile of insulin
Number of subjects: 591
Study 28698186 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMA‐IR
Number of subjects: 591
Study 28698186 — intervention group
Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 591
Study 28698186 — intervention group
Group type: COMPARATOR
Intervention: Insulin:glucose molar ratio
Number of subjects: 591
Study 25241271 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in diastolic blood pressure ≥15 mmHg
Number of subjects: 209
Study 25241271 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline diastolic blood pressure of ≥80 mmHg
Number of subjects: 209
Study 25241271 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic and diastolic blood pressures at pregnancy week 12
Number of subjects: 209
Study 23404232 — intervention group
Group type: EXPERIMENTAL
Intervention: Regadenoson at peak exercise
Number of subjects: 200
Study 23404232 — intervention group
Group type: COMPARATOR
Intervention: Standard regadenoson injection at rest
Number of subjects: 200
Study 21827166 — intervention group
Group type: EXPERIMENTAL
Intervention: SODIS (solar disinfection of drinking water)
Number of subjects: 928
Study 21827166 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 928
Study 19839214 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 17144782 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 0
Study 17144782 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 17144782 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty and stenting
Number of subjects: 0
Study 17144782 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet agents
Number of subjects: 0
Study 15075878 — intervention group
Group type: EXPERIMENTAL
Intervention: Pterygium surgery using bare sclera technique combined with intraoperative mitomycin C
Number of subjects: 54
Study 11207992 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-fed infants
Number of subjects: 671
Study 11207992 — intervention group
Group type: COMPARATOR
Intervention: Formula-fed infants
Number of subjects: 671
Study 9394313 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 130
Study 9394313 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 130
Study 7614283 — intervention group
Group type: EXPERIMENTAL
Intervention: Proparacaine
Number of subjects: 23
Study 7614283 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine
Number of subjects: 23
Study 2953501 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil bolus 0.1 microgram X kg‐1 followed by continuous sufentanil infusion of 0‐7 micrograms X min‐1
Number of subjects: 50
Study 2953501 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl bolus 0.7 microgram X kg‐1 followed by continuous fentanyl infusion of 0‐50 micrograms X min‐1
Number of subjects: 50
Study 29655134 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM) intervention (UC + 4 weeks of small, abstinence contingent financial incentives)
Number of subjects: 139
Study 29655134 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) including pharmacotherapy and counseling sessions
Number of subjects: 139
Study 27737692 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders to PSA testing invitation
Number of subjects: 197763
Study 27737692 — intervention group
Group type: COMPARATOR
Intervention: Nonresponders to PSA testing invitation
Number of subjects: 197763
Study 25675682 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby EAR
Number of subjects: 20